Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring of Asparaginase: Intra-individual Variability and Predictivity in Children With Acute Lymphoblastic Leukemia Treated With PEG-Asparaginase in the AIEOP-BFM Acute Lymphoblastic Leukemia 2009 Study

Published:2020-06 Issue:3 Volume:42 Page:435-444
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Würthwein Gudrun,Lanvers-Kaminsky Claudia,Gerss Joachim,Möricke Anja,Zimmermann Martin,Stary Jan,Smisek Petr,Attarbaschi Andishe,Nath Christa,Zucchetti Massimo,Rizzari Carmelo,Schrappe Martin,Boos Joachim

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols;Müller;Br J Haematol.,2000

2. Comparative pharmacokinetic studies of three asparaginase preparations;Asselin;J Clin Oncol.,1993

3. Peg-asparaginase for acute lymphoblastic leukemia;Rytting;Expert Opin Biol Ther.,2010

4. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial;Place;Lancet Oncol.,2015

5. Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511;Wetzler;Blood.,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The correlation of asparaginase enzyme activity levels after PEG‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia;British Journal of Haematology;2024-06-27

2. Determination of l-Asparaginase Activity and Its Therapeutic Monitoring in Children with Hematological Malignancies in a Single Croatian Center;Diagnostics;2024-03-15

3. Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol;HemaSphere;2023-06

4. Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia;Annals of Hematology;2023-01-18

5. Asparaginase activity monitoring in pediatric acute lymphoblastic leukemia: A cross‐sectional nationwide study in Spain;Cancer Reports;2022-10-28